Marloes G. J. van Dongen

Evaluation of the EndoPAT as a Tool to Assess Endothelial Function

Matthijs Moerland, Anthony Kales, Lenneke Schrier et al. · International Journal of Vascular Medicine · 2012 · 161 citations · Full text

Medicine, Nephrology, Pharmacology +12

Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis

Marlous R. Dillingh, Bernt van den Blink, Matthijs Moerland et al. · Pulmonary Pharmacology & Therapeutics · 2013 · 98 citations

Medicine, Clinical Sciences, Pathobiology +12

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

Aurélien Marabelle, Philippe A. Cassier, Marwan Fakih et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 73 citations · Full text

Medicine, Oncology, Pharmacology +7

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

Iris Nederlof, Olga I. Isaeva, Manon de Graaf et al. · Nature Medicine · 2024 · 67 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study

Ronnie Shapira‐Frommer, Linda Mileshkin, L. V. Manzyuk et al. · Gynecologic Oncology · 2022 · 62 citations

Medicine, Oncology, Pharmacology +13